Picture of Clariane SE logo

CLARI Clariane SE News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapNeutral

Brief: Clariane Lowers 2025 Full Year EBITDA Target

Oct 27 (Reuters) - Clariane SE CLARI.PA:

SALES AT 30 SEPTEMBER 2025 WERE €3,976M

ORGANIC SALES GROWTH TARGET CONFIRMED

EBITDA, PRE-IFRS 16 AND PRO FORMA FOR DISPOSALS FOR THE FULL YEAR IS EXPECTED TO INCREASE, ALTHOUGH AT A LEVEL BELOW THE INITIAL RANGE OF +6% TO +9%

Source text: https://tinyurl.com/bvr4f8dd

Further company coverage: CLARI.PA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Clariane SE

See all news